Supply intelligence must respect controlled decisions
Medical device teams need to investigate supplier warnings without bypassing quality, engineering, or regulatory controls. A notice about a supplier, material, or component does not establish which device family, specification, manufacturing site, or released product is affected. The operational task is to connect the signal to controlled records and route the assessment to an authorized owner.
Medical device supply chain risk software can support that coordination by preserving the source, showing available business context, and tracking evidence and actions. It should not turn incomplete external information into an automatic compliance or product-safety conclusion.
A supplier-change scenario
Suppose a supplier announces that a component will move to another manufacturing site within the next quarter. The component is listed for two device families, but only one current specification names the existing site in its approved-source context. Open purchase orders cover several delivery dates, and the supplier has not yet provided the evidence requested by quality.
Purchasing confirms the notice, supplier entity, component, current site, proposed site, and affected orders. Quality and engineering review the controlled specification, approved supplier record, quality agreement, validation implications, and required change process. Operations identifies upcoming demand, while the responsible commercial team considers customer commitments if supply timing becomes uncertain.
The shared investigation should make clear that the site change is proposed, the device impact is under review, and no approval has been granted by the software. It can assign the supplier document request and internal assessment separately, each with an owner and due date. The final closure note then points to the authorized decision and evidence.
Evidence and context for review
Relevant data can include supplier and manufacturing site, internal component, specification revision, approved-source status, device family, production or purchase order, required date, inventory context, and customer commitment. Identifiers such as a Basic UDI-DI may help orient the review when they are part of the organization’s controlled data, but they do not replace the underlying product records.
Evidence may include the original supplier notice, quality agreement, certificate, specification, supplier response, order extract, authorized assessment, and change record reference. Each document should retain its version or date where available. A missing certificate or unanswered questionnaire is an evidence gap that needs follow-up, not proof of nonconformity.
How adelvy supports the workflow
adelvy can organize warnings around imported or prepared supplier, site, material, order, customer, and document records. The user reviews the source and follows the known relationships to the operational records that may require assessment. If a device, site, or order relationship is missing, the gap can become a task or supplier question.
A warning can be converted into a case with ownership, due dates, status, comments, supplier requests, attachments, and decision history. The team can keep a supply-continuity action distinct from a quality or engineering assessment while viewing both in the same case context. Management can review open exposure and aging actions without interpreting the case as a regulatory determination.
The workflow helps lean teams coordinate information that otherwise sits across inboxes, spreadsheets, order systems, and document repositories. Its conclusions remain limited by the quality and completeness of those sources.
What a useful outcome looks like
A closed medical device supply case should identify the component, supplier site, device-family context, orders, and controlled records reviewed. It should point to the authorized quality or engineering conclusion instead of restating it as a software-generated decision. Teams can monitor supplier requests awaiting evidence, cases without an assigned reviewer, and orders waiting for a documented assessment. These operational measures do not establish product safety, conformity, or regulatory compliance.
Product boundary
adelvy does not replace a quality management system, electronic document control, PLM, ERP, manufacturing execution, complaint handling, vigilance, EUDAMED, or regulatory submission tools. It does not approve a supplier change, determine reportability, release product, validate a process, certify conformity, or guarantee compliance with the Medical Devices Regulation or other requirements.
Authorized quality, engineering, regulatory, and operational personnel remain responsible for controlled decisions. adelvy supports their investigation by keeping the warning, possible business exposure, missing evidence, assigned actions, and referenced decision together.